SAN DIEGO, CA, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has hired Jeanne Rawdin as the Company’s Global Communications Ma
Rawdin joins Kannaway® after establishing a successful career in broadcast journalism, marketing, and storytelling. She previously served as an on-air reporter and managing producer for several of San Diego’s leading broadcast news stations, a communications specialist for LifeWave, Inc., and a media advisor for the University of California, San Diego. In addition, Rawdin also founded her own content production company, Epic Storytelling.
“As a Company that operates around the world and continues to establish operations in new countries, our need for a cohesive communications strategy and team has become more apparent than ever,” said Kannaway® CEO Blake Schroeder. “We are confident that Jeanne has the skills and expertise to help us improve our internal and external communication and reach more customers this year.”
“I’m looking forward to working with a team of professionals that understands the importance of creating messages and content that not only educate but also inspire,” said Kannaway® Global Communications Manager Jeanne Rawdin. “In my new role, I will ensure that the Company’s messages about its products, business opportunities, and wellness initiatives are shared around the world in a memorable way.”
To learn more about Kannaway®, please visit the Company online at https://www.kannaway.com/.
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.
Investor Relations Contact:
P. (858) 283-4016